ABT DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
October 05, 2022 16:58 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
September 27, 2022 14:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action
September 22, 2022 13:08 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
September 17, 2022 12:10 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 17, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
September 12, 2022 10:33 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed
September 07, 2022 18:42 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb....
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed
September 02, 2022 18:46 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...